Back to Miscellaneous News
Rimon, P.C. Adds Leading Intellectual Property and Biotechnology Partner Holly Logue
Wednesday, April 24, 2013
Expanding its burgeoning intellectual property practice, Rimon, P.C. has added Holly Logue, a former Capitol Hill staffer who counsels companies on IP transactional issues, as a partner in its Los Angeles and Washington, DC offices.
Ms. Logue has worked extensively with innovative biotechnology and medical device companies to maximize their intellectual property through patent prosecution strategy, patent portfolio management, due diligence, corporate counseling, licensing, M&A and other transactional matters.
Ms. Logue previously worked as professional staffer on the House of Representative’s Subcommittee on Technology and Innovation. While at the subcommittee, Ms. Logue drafted legislation for the America COMPETES Act, proposing standards and procedures to support biologic drug development, diagnostics and personalized medicine.
She was also responsible for Congressional oversight of the National Institute of Standards and Technology in its efforts to develop programs in biologic drug development, personalized medicine and diagnostic tools to reduce the cost of healthcare and improve patient care.
Rimon has greatly enhanced its IP group by adding a number of significant IP attorneys, including Wade Savoy, former Assistant General Counsel of Intellectual Property at Walmart, patent prosecutor John Boyd in New York, patent litigator Paul Beattie in Seattle, licensing lawyer Fred Tsien in Silicon Valley, technology transaction lawyers Paul Economon in Northern Virginia, Carl Sherer in Tel Aviv, and Sandy Sterret in Washington, DC. The firm has gained wide recognition for handling cutting edge technology work.
Since its inception five years ago, Rimon has become widely recognized as an innovator in the legal field, offering a full service of practices based solely on present client needs, with the ability to quickly shift and adapt to challenges. The firm was recently named by the Financial Times on its Innovative Lawyers 2012 list and the firm’s managing partners were recently honored as ‘Legal Rebels’ by the ABA Journal.
“Holly is exactly the type of attorney we look for, someone with a drive to help companies unlock the full potential of their assets. She has repeatedly worked with early stage companies in crafting innovative solutions to maximize their IP portfolios and effectively get their properties to the marketplace. Holly’s thorough understanding of the key business issues facing tech and biotech companies will be a great fit with Rimon’s highly-experienced IP group,” said Michael Moradzadeh, CEO of Rimon, P.C.
Following her tenure in the House, Ms. Logue founded 17th Street Legal PLLC (since renamed Logue PLLC). Among the recent transactions she has worked on include:
- Managing and prosecuting the patent portfolio for a development-stage oncology company, including advising and preparing the company for a diligence review in connection with a $30M round of financing, strategically expanding patent protection for key products, managing patent litigation, drafting and providing strategic counseling for multiple transactions, and conducting freedom to operate and other diligence reviews.
- Drafting and negotiating a key license agreement to launch a new medical device company and drafting their key patents.
- Managing and prosecuting the patent portfolio for an early stage biotechnology company focused on providing genetically modified large animal models for drug development and research, and advising on key intellectual property transactions.
“I was looking for ways to expand my practice and get additional support for clients. Rimon has a strong group of attorneys that know the ins and outs of IP transactions. The firm also has a great reputation for focusing on quality and innovation. Much like its clients, Rimon is a firm that constantly looks for better ways to improve quality,” said Ms. Logue.
Earlier in her career, Holly worked as an associate at Arnold & Porter for eight years, where she advised companies on the full range of IP matters.
“It is a pleasure and honor to be able to continue working to get new drugs and new medical devices out of the lab and into the marketplace, where they can start directly benefitting people. Biotech is a field that really showcases the impact our work has on everyday lives,” said Ms. Logue.
Ms. Logue currently serves as chair for the Women in Bio Southern California Chapter.
Ms. Logue received her JD from The University of Michigan School of Law and her B.S. in biochemistry from the University of Michigan, where she was also an All Big Ten Scholar-Athlete Honoree for outstanding achievement in track and cross-country.
Back to Miscellaneous News